Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 698

1.

Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis.

Janssens HJEM, Fransen J, Janssen M, Neogi T, Schumacher HR, Jansen TL, Dalbeth N, Taylor WJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1335-1341. doi: 10.1093/rheumatology/kex164.

PMID:
28431109
2.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

3.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

4.

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ.

Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Erratum in: Ann Rheum Dis. 2016 Feb;75(2):473.

5.

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ.

Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Erratum in: Arthritis Rheumatol. 2016 Feb;68(2):515. Vaquez-Mellado, Janitzia [corrected to Vazquez-Mellado, Janitzia].

6.

Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.

Vargas-Santos AB, Castelar-Pinheiro Gda R, Coutinho ES, Schumacher HR Jr, Singh JA, Schlesinger N.

PLoS One. 2015 Aug 14;10(8):e0135805. doi: 10.1371/journal.pone.0135805. eCollection 2015.

7.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-1315. doi: 10.1002/acr.22585.

8.

A nice reminder from a former patient to consider hemochromatosis as a cause of arthritis.

Schumacher HR Jr.

J Clin Rheumatol. 2015 Jan;21(1):1-2. doi: 10.1097/RHU.0000000000000211. No abstract available.

PMID:
25539425
9.

Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.

Mo YQ, Liang AQ, Ma JD, Chen LF, Zheng DH, Schumacher HR, Dai L.

BMC Musculoskelet Disord. 2014 Dec 22;15:449. doi: 10.1186/1471-2474-15-449.

10.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
11.

An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks.

Liang MH, Couto MC, Duarte CC, Gall V, White P, Naides S, Schumacher HR Jr, Hwang AS, Holers VM, Deane KD, Gupta S, Ho IC, Finckh A, Kopec J, Choi CB, Sayre EC.

Clin Rheumatol. 2015 Mar;34(3):465-70. doi: 10.1007/s10067-014-2796-7. Epub 2014 Oct 24.

PMID:
25339123
12.

Some suggestions for reviewers and for authors to know what reviewers may be looking for.

Schumacher HR Jr, Von Feldt JM.

J Clin Rheumatol. 2014 Aug;20(5):241-3. doi: 10.1097/RHU.0000000000000132. No abstract available.

PMID:
25057739
13.

Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study.

Sundy JS, Schumacher HR, Kivitz A, Weinstein SP, Wu R, King-Davis S, Evans RR.

J Rheumatol. 2014 Aug;41(8):1703-11. doi: 10.3899/jrheum.131226. Epub 2014 Jul 15.

PMID:
25028379
14.

Imaging modalities for the classification of gout: systematic literature review and meta-analysis.

Ogdie A, Taylor WJ, Weatherall M, Fransen J, Jansen TL, Neogi T, Schumacher HR, Dalbeth N.

Ann Rheum Dis. 2015 Oct;74(10):1868-74. doi: 10.1136/annrheumdis-2014-205431. Epub 2014 Jun 10. Review.

15.

Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout.

Taylor WJ, Redden D, Dalbeth N, Schumacher HR, Edwards NL, Simon LS, John MR, Essex MN, Watson DJ, Evans R, Rome K, Singh JA.

J Rheumatol. 2014 Mar;41(3):574-80. doi: 10.3899/jrheum.131245. Epub 2014 Jan 15.

16.

Evaluating appropriate use of prophylactic colchicine for gout flare prevention.

George M, Pullman-Mooar S, Hussain F, Schumacher HR.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1258-62. doi: 10.1002/acr.22275.

17.

OMERACT endorsement of measures of outcome for studies of acute gout.

Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL.

J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15.

18.

Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells.

Pessler F, Ogdie AR, Mayer CT, Kretzschmar WW, Dai L, Elsaman AM, Einhorn E, Krenn V, Schumacher HR.

Amyloid. 2014 Mar;21(1):28-34. doi: 10.3109/13506129.2013.862229. Epub 2013 Nov 28.

19.

Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases.

Elsaman AM, Radwan AR, Akmatov MK, Della Beffa C, Walker A, Mayer CT, Dai L, Nativ S, Rygg M, Atsali E, Saijo K, Ogdie AR, Srinivasulu N, Fathi N, Schumacher HR, Pessler F.

Semin Arthritis Rheum. 2013 Dec;43(3):405-12. doi: 10.1016/j.semarthrit.2013.07.004. Epub 2013 Aug 28.

PMID:
23992800
20.

Integrating acupuncture with exercise-based physical therapy for knee osteoarthritis: a randomized controlled trial.

Chen LX, Mao JJ, Fernandes S, Galantino ML, Guo W, Lariccia P, Teal VL, Bowman MA, Schumacher HR, Farrar JT.

J Clin Rheumatol. 2013 Sep;19(6):308-16. doi: 10.1097/RHU.0b013e3182a21848.

21.

The relative composition of the inflammatory infiltrate as an additional tool for synovial tissue classification.

Della Beffa C, Slansky E, Pommerenke C, Klawonn F, Li J, Dai L, Schumacher HR Jr, Pessler F.

PLoS One. 2013 Aug 8;8(8):e72494. doi: 10.1371/journal.pone.0072494. eCollection 2013.

22.

Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China.

Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ, Schumacher HR.

Clin Rheumatol. 2013 Nov;32(11):1633-40. doi: 10.1007/s10067-013-2333-0. Epub 2013 Jul 16.

PMID:
23857664
23.

Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee.

Schumacher HR, Pullman-Mooar S, Gupta SR, Dinnella JE, Kim R, McHugh MP.

Osteoarthritis Cartilage. 2013 Aug;21(8):1035-41. doi: 10.1016/j.joca.2013.05.009. Epub 2013 May 31.

24.

Readability and suitability assessment of patient education materials in rheumatic diseases.

Rhee RL, Von Feldt JM, Schumacher HR, Merkel PA.

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1702-6. doi: 10.1002/acr.22046.

25.

Are we being open enough to all approaches to therapy of rheumatoid arthritis?

Schumacher HR.

J Clin Rheumatol. 2013 Jun;19(4):167-71. doi: 10.1097/RHU.0b013e318293ef40. No abstract available.

PMID:
23669810
26.

New classification criteria for gout: a framework for progress.

Dalbeth N, Fransen J, Jansen TL, Neogi T, Schumacher HR, Taylor WJ.

Rheumatology (Oxford). 2013 Oct;52(10):1748-53. doi: 10.1093/rheumatology/ket154. Epub 2013 Apr 22. Review.

27.

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.

Mitha E, Schumacher HR, Fouche L, Luo SF, Weinstein SP, Yancopoulos GD, Wang J, King-Davis S, Evans RR.

Rheumatology (Oxford). 2013 Jul;52(7):1285-92. doi: 10.1093/rheumatology/ket114. Epub 2013 Mar 13.

PMID:
23485476
28.

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria.

Prowse RL, Dalbeth N, Kavanaugh A, Adebajo AO, Gaffo AL, Terkeltaub R, Mandell BF, Suryana BP, Goldenstein-Schainberg C, Diaz-Torne C, Khanna D, Lioté F, Mccarthy G, Kerr GS, Yamanaka H, Janssens H, Baraf HF, Chen JH, Vazquez-Mellado J, Harrold LR, Stamp LK, Van De Laar MA, Janssen M, Doherty M, Boers M, Edwards NL, Gow P, Chapman P, Khanna P, Helliwell PS, Grainger R, Schumacher HR, Neogi T, Jansen TL, Louthrenoo W, Sivera F, Taylor WJ, Alten R.

J Rheumatol. 2013 Apr;40(4):498-505. doi: 10.3899/jrheum.121037. Epub 2013 Feb 15. Erratum in: J Rheumatol. 2013 Sep;40(9):1634. Alten, Rieke [added].

PMID:
23418379
29.

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.

Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP.

Arthritis Res Ther. 2013 Feb 1;15(1):R25. doi: 10.1186/ar4159.

30.

A qualitative and quantitative analysis of the characteristics of gout patient education resources.

Robinson PC, Schumacher HR Jr.

Clin Rheumatol. 2013 Jun;32(6):771-8. doi: 10.1007/s10067-013-2168-8. Epub 2013 Jan 16.

PMID:
23322247
31.

Guidelines and algorithms: a call for evaluation of their use and effects.

Schumacher HR.

J Clin Rheumatol. 2012 Dec;18(8):387-8. doi: 10.1097/RHU.0b013e31827cd9da. No abstract available.

PMID:
23211584
32.

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61. doi: 10.1002/acr.21773. No abstract available.

33.

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772. No abstract available.

34.

Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial.

Schumacher HR, Berger MF, Li-Yu J, Perez-Ruiz F, Burgos-Vargas R, Li C.

J Rheumatol. 2012 Sep;39(9):1859-66. doi: 10.3899/jrheum.110916. Epub 2012 Aug 1.

PMID:
22859357
35.

Light and electron microscopic features of synovium in patients with psoriatic arthritis.

Zhang LY, Ogdie AR, Schumacher HR.

Ultrastruct Pathol. 2012 Aug;36(4):207-18. doi: 10.3109/01913123.2011.651523.

PMID:
22849522
36.

The structure of affective symptomatology in older adults with osteoarthritis.

Parmelee PA, Harralson TL, McPherron JA, Schumacher HR.

Int J Geriatr Psychiatry. 2013 Apr;28(4):393-401. doi: 10.1002/gps.3837. Epub 2012 Jun 1.

37.

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.

Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK.

Ann Rheum Dis. 2012 Nov;71(11):1839-48. doi: 10.1136/annrheumdis-2011-200908. Epub 2012 May 14.

PMID:
22586173
38.

The time has come to incorporate more teaching and formalized assessment of skills in synovial fluid analysis into rheumatology training programs.

Schumacher HR, Chen LX, Mandell BF.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1271-3. doi: 10.1002/acr.21714. No abstract available.

39.

Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.

Schumacher HR Jr, Evans RR, Saag KG, Clower J, Jennings W, Weinstein SP, Yancopoulos GD, Wang J, Terkeltaub R.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1462-70. doi: 10.1002/acr.21690.

40.

Platelets can enhance vascular permeability.

Cloutier N, Paré A, Farndale RW, Schumacher HR, Nigrovic PA, Lacroix S, Boilard E.

Blood. 2012 Aug 9;120(6):1334-43. doi: 10.1182/blood-2012-02-413047. Epub 2012 Apr 27.

PMID:
22544703
41.

Synovial xanthomatosis: are there clues to mechanisms for this rare disease?

Schumacher HR, Habre WG, Friedrich C, Sieck M, Chen LX, Clayburne GM, Von Feldt JM.

Mod Rheumatol. 2012 Nov;22(6):907-11. doi: 10.1007/s10165-012-0592-2. Epub 2012 Feb 10.

PMID:
22322588
42.

Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.

Schumacher HR Jr, Sundy JS, Terkeltaub R, Knapp HR, Mellis SJ, Stahl N, Yancopoulos GD, Soo Y, King-Davis S, Weinstein SP, Radin AR; 0619 Study Group.

Arthritis Rheum. 2012 Mar;64(3):876-84. doi: 10.1002/art.33412.

43.

Developing a provisional definition of flare in patients with established gout.

Gaffo AL, Schumacher HR, Saag KG, Taylor WJ, Dinnella J, Outman R, Chen L, Dalbeth N, Sivera F, Vázquez-Mellado J, Chou CT, Zeng X, Perez-Ruiz F, Kowalski SC, Goldenstein-Schainberg C, Chen L, Bardin T, Singh JA.

Arthritis Rheum. 2012 May;64(5):1508-17. doi: 10.1002/art.33483.

44.

Evaluation of glyceraldehyde-3-phosphate, prolylpeptidyl isomerase A, and a set of stably expressed genes as reference mRNAs in urate crystal inflammation.

Della Beffa C, Klawonn F, Menetski JP, Schumacher HR Jr, Pessler F.

BMC Res Notes. 2011 Oct 25;4:443. doi: 10.1186/1756-0500-4-443.

45.

Clinical images: synovial fluid clues to ochronosis.

Bhangle S, Panush RS, Berman EL, Schumacher HR.

Arthritis Rheum. 2012 Feb;64(2):473. doi: 10.1002/art.33409. No abstract available.

46.

Patient education: How can we improve it and evaluate the effects?

Schumacher HR.

J Clin Rheumatol. 2011 Aug;17(5):229-30. doi: 10.1097/RHU.0b013e31822d9a51. No abstract available.

PMID:
21808182
47.

Unusual draining nodules in a patient with rheumatoid nodulosis and hepatitis C virus infection.

Wen H, Schumacher HR, Pullman-Mooar SW, Einhorn E.

J Rheumatol. 2011 Aug;38(8):1806-8. doi: 10.3899/jrheum.110244. No abstract available.

PMID:
21807805
48.

Development and evaluation of a survey of gout patients concerning their knowledge about gout.

Zhang LY, Schumacher HR, Su HH, Lie D, Dinnella J, Baker JF, Von Feldt JM.

J Clin Rheumatol. 2011 Aug;17(5):242-8. doi: 10.1097/RHU.0b013e318228b4e2.

PMID:
21778899
49.

Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials.

Taylor WJ, Singh JA, Saag KG, Dalbeth N, MacDonald PA, Edwards NL, Simon LS, Stamp LK, Neogi T, Gaffo AL, Khanna PP, Becker MA, Schumacher HR Jr.

J Rheumatol. 2011 Jul;38(7):1467-70. doi: 10.3899/jrheum.110274.

PMID:
21724718
50.

Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Stamp LK, Khanna PP, Dalbeth N, Boers M, Maksymowych WP, Schumacher HR Jr, Becker MA, MacDonald PA, Edwards NL, Singh JA, Simon LS, McQueen FM, Neogi T, Gaffo AL, Strand V, Taylor WJ.

J Rheumatol. 2011 Jul;38(7):1462-6. doi: 10.3899/jrheum.110273.

Supplemental Content

Loading ...
Support Center